Several U.S. Food and Drug Administration (FDA) employees involved in the review of Tesla Chief, Elon Musk‘s private brain implant company, Neuralink, were reportedly dismissed over the weekend. The cuts reportedly affected about 20 individuals from the FDA’s Office of Neurological and Physical Medicine Devices, including several who were working on Neuralink, reported Reuters on Tuesday.
